SEOM clinical guidelines for cancer anorexia-cachexia syndrome (2023)
Clinical and Translational Oncology · 01.06.2024 · 26 (11) · 2866-2876
DOI: 10.1007/s12094-024-03502-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Oncology, online erschienen am 01.06.2024. Verfasst von Ainara Soria Rivas und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Hospital Univ. Ramón y Cajal, Madrid, Spain. ainarasoria@hotmail.com. Hauptthemen laut MEDLINE: Anorexia, Cachexia, Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer-related anorexia-cachexia syndrome (CACS) is a debilitating condition afflicting up to 80% of advanced-stage cancer patients. Characterized by progressive weight loss, muscle wasting, and metabolic abnormalities, CACS significantly compromises patients’ quality of life and treatment outcomes. This comprehensive review navigates through its intricate physiopathology, elucidating its stages and diagnostic methodologies. CACS manifests in three distinct stages: pre-cachexia, established cachexia, and refractory cachexia. Early detection is pivotal for effective intervention and is facilitated by screening tools, complemented by nutritional assessments and professional evaluations. The diagnostic process unravels the complex interplay of metabolic dysregulation and tumor-induced factors contributing to CACS. Management strategies, tailored to individual patient profiles, encompass a spectrum of nutritional interventions. These include dietary counseling, oral nutritional supplements, and, when necessary, enteral nutrition and a judicious use of parenteral nutrition. Specific recommendations for caloric intake, protein requirements, and essential nutrients address the unique challenges posed by CACS. While pharmacological agents like megestrol acetate may be considered, their use requires careful evaluation of potential risks. At its core, this review underscores the imperative for a holistic and personalized approach to managing CACS, integrating nutritional interventions and pharmacological strategies based on a nuanced understanding of patient’s condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Oncology Department, Hospital Univ. Ramón y Cajal, Madrid, Spain. ainarasoria@hotmail.com.
- Medical Oncology Department, Hospital General Univ. Gregorio Marañón, Madrid, Spain.
- Medical Oncology Department, Consorcio Hospital General Univ. de Valencia, Valencia, Spain.
- Medical Oncology Department, Hospital de La Santa Creu I Sant Pau, Barcelona, Spain.
- Medical Oncology Department, Hospital Duran I Reynals, Institut Català D'Oncologia L'Hospitalet (ICO), Barcelona, Spain.
- Endocrinology and Nutrition Department, Hospital General Univ. Gregorio Marañón, Madrid, Spain.
Zitieren
APA
Soria Rivas, A., Escobar Álvarez, Y., Blasco Cordellat, A., Majem Tarruella, M., Molina Mata, K., Motilla de la Cámara, M., Del Mar Muñoz Sánchez, M., Zafra Poves, M., Beato Zambrano, C., & Cabezón Gutierrez, L. (2024). SEOM clinical guidelines for cancer anorexia-cachexia syndrome (2023). Clinical and Translational Oncology, 26(11), 2866-2876. https://doi.org/10.1007/s12094-024-03502-8
Vancouver
Soria Rivas A, Escobar Álvarez Y, Blasco Cordellat A, Majem Tarruella M, Molina Mata K, Motilla de la Cámara M, et al. SEOM clinical guidelines for cancer anorexia-cachexia syndrome (2023). Clinical and Translational Oncology. 2024;26(11):2866-2876. doi:10.1007/s12094-024-03502-8
BibTeX
@article{SoriaRivas2024,
author = {Soria Rivas, Ainara and Escobar Álvarez, Yolanda and Blasco Cordellat, Ana and Majem Tarruella, Margarita and Molina Mata, Kevin and Motilla de la Cámara, Marta and Del Mar Muñoz Sánchez, Mª and Zafra Poves, Marta and Beato Zambrano, Carmen and Cabezón Gutierrez, Luis},
title = {SEOM clinical guidelines for cancer anorexia-cachexia syndrome (2023)},
journal = {Clinical and Translational Oncology},
year = {2024},
volume = {26},
number = {11},
pages = {2866--2876},
doi = {10.1007/s12094-024-03502-8}
}
EUVIMED